Skip to content
Neuronet
Neuronet - The support action for EU research on neurodegeneration
  • ABOUT
        • Objectives
        • Glossary
        • Work Packages
        • Partners
        • Executive Committee
        • Task Forces
        • Working Groups
        • Scientific Coordination Board
  • EVENTS
        • 2021: Virtual event
        • 2020: Virtual Event
        • 2019: The Hague
        • Event Calendar
  • NEWS
        • Latest news
        • Neuronet newsletters
        • Neuronet in the Media
  • PROJECTS
        • Ongoing Projects
        • Completed Projects
        • Project Overview
        • Project Timescales
  • RESOURCES
        • Asset Map
        • Project Tools
        • Regulatory & HTA Decision Tool
        • Neuronet Tools
        • Neuronet Deliverables
        • Neuronet Presentations
        • Publications
        • Useful resources for young researchers
  • KNOWLEDGE BASE

Sin categoría

Development of the digital RADAR-BASE platform within the framework of RADAR-AD and RADAR-CNS

21st January 20227th April 2020
Development of the digital RADAR-BASE platform within the framework of RADAR-AD and RADAR-CNS 800x535

The IMI RADAR-AD project aims to develop a digital platform to remotely collect data from smartphone applications, wearable devices

More than 1,000 clinicians complete RMT survey for the RADAR-CNS project

4th November 20203rd April 2020
RADAR-CNS logo

The Clinical Pathways team of the RADAR-CNS project has surveyed 1,009 clinicians as to identify

Mercè Boada, leader of the MOPEAD project, shares her experiences of COVID-19 lockdown

4th November 20201st April 2020
Mercè Boada, MOPEAD Project Coordinator

During the lockdown, I am distancing myself socially whilst continuing my work for Fundació ACE.

EPAD Coordinators comment on closure of Longitudinal Cohort Study

4th November 202027th March 2020
EPAD - European prevention of Alzheimer’s dementia consortium

By now you will perhaps already be aware of the unexpected closure of the EPAD

FRAUNHOFER repurposes technologies from the AETIONOMY project to fight SARS-CoV-2

4th November 202025th March 2020
AETIONOMY logo Organising Knowledge about Neurodegenerative Disease Mechanisms for the Improvement of Drug Development and Therapy

In the course of the AETIONOMY project, Martin Hofmann-Apitius (Fraunhofer SCAI) and partners developed new

Leadership blog with Jean Georges from Alzheimer Europe, Dissemination & Outreach Co-Leader

25th March 2020
Jean Georges, Neuronet Communication and Dissemination Work Package Co-leader, Neuronet Leadership interview

What is your current role in the organisation you work at? I am Executive Director at

Leadership blog with Carlos Díaz from SYNAPSE, Neuronet Coordinator

24th March 2020
Carlos Diaz, Neuronet leadership blog

What is your current role in the company you work at? I am the founder

Leadership blog with Lennert Steukers from Janssen, Neuronet Project Leader

23rd March 2020
20180718 Beerse Belgie: Lennert Steukers, DVM, PhD Clinical Scientist - Experimental Medicine Neuroscience bij Janssen Pharmaceutica NV . Copyright Bart Dewaele

What is your current role in the company you work at? I’m currently working as

Leadership blog with Antonella Santuccione Chadha from Roche, Dissemination & Outreach Co-Leader

27th March 202021st March 2020

What is your current role in the company you work at? Alzheimer’s disease Partnership Lead

Consultation meeting at EMA: Joint effort of the RADAR-CNS and RADAR-AD consortium members

4th November 202018th March 2020
RADAR-AD Remote assessment of disease and relapse – Alzheimer’s disease

On the 4th of February 2020, RADAR-CNS and RADAR-AD project members visited the European Medicines

Post navigation
Older posts
Newer posts
← Previous Page1 … Page21 Page22 Page23 … Page29 Next →

LATEST NEWS

  • Neuronet publishes Frontiers in Neurology article, analysing the structure, assets and collaborative networks in the IMI neurodegeneration portfolio

    9th November 2022
    The Innovative Medicines Initiative (IMI) was launched in 2008, with an initial budget of €8bn.Read More
  • Spotlight on Early-Career researchers a Neuronet interview with Ilja Saris

    5th September 2022
    In this Neuronet spotlight on early-career researcher interview, we speak with Ilja Saris who worksRead More
  • Spotlight on Communication experts: A Neuronet Blog with Cindy Birck

    29th August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More
  • Webinar series: Mobilise-D presents its four patient cohorts

    25th August 2022
    Mobilise-D starts the autumn webinar series presenting the needs, technologies, protocols and user perspectives forRead More
  • Spotlight on Communication experts: A Neuronet Blog with Yoanna de Geus

    23rd August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More

Neuronet

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 821513. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

Any information on this website solely reflects the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

 

 

Innovative Medicines InitiativeEU Flag logoEuropean Federation of Pharmaceutical Industries and Associations logoParksinson's UK logo

Disclaimer
About IMI
Legal notice
Privacy policy

@ 2019 – IMI-NEURONET

© 2026 - IMI-NEURONET
We use cookies to offer you a better browsing experience and to analyze site traffic. Read about how we use cookies and how you can control them in our Cookie Policy. If you continue to use this site, you consent to our use of cookies. AcceptCookie policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT